Skip to main content

Industrial Apparatuses in Confrontation

From the series The struggle against coronavirus

According to the British analyst firm Airfinity, some 9.5 billion doses of Covid-19 vaccines will be produced worldwide in 2021. This number is double the annual production of all types of vaccines in the pre-pandemic era (5 billion, excluding oral polio, travellers’ and military vaccines), and can be compared with the requirement of 11.5 billion to immunise two-thirds of the world’s population [Airfinity, March 8th]. The development of vaccines has been exceptionally rapid, but manufacturing them on a large scale has encountered difficulties and delays. In 2020, only 4% of the expected doses were in fact produced [ibidem].

Production is concentrated in a limited number of countries, largely interdependent due to supply chains that cross state borders and continents. The World Bank identifies, among the producing countries, a Covid-19 vaccine producers club of 13 countries that manufacture both the active ingredient and its components. This exclusive Vaccine Club is also awarded 60% of the total Advance Purchase Agreements (APAs) — the advance purchase of vaccines — with pharmaceutical companies [World Bank, The Covid-19 vaccine production club, March 2021].

The World Bank’s concern is that aggressive forms of vaccine nationalism , by limiting exports, are disrupting global supply chains. For its part, the World Health Organization (WHO) fears that in much of the world, such as in Africa, vaccines will not arrive until 2023 or 2024.

Crippled internationalism

In June last year, the Global Vaccine Alliance (GAVI), together with the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO, launched the COVAX programme. It covers 192 countries, with the aim of ensuring equitable global distribution of vaccines, initially providing two billion doses, two-thirds free of charge, to 92 lower-income countries. Donations were in short supply and, two months into the vaccination campaign, COVAX had still not been able to deliver a single dose to the poorest countries [Financial Times, February 13th]. Initially conceived as a single clearing house for vaccine orders around the world, from which all countries, rich and poor, would procure their doses, notes the City newspaper, the program almost immediately foundered in the race for bilateral deals between the richest nations and the vaccine companies, and the priority allocation to domestic needs practised by countries like the United States, the UK and, more recently, even India.

Limited production, coupled with the supply dispute that has arisen between the European Commission and pharmaceutical companies — in particular with the Anglo-Swedish company AstraZeneca — has prompted several European leaders (and various scientific and political figures) to raise the issue of patents. The President of the European Council Charles Michel at the beginning of the year raised the possibility of the EU adopting ‘urgent measures’ — provided for in Article 122 of the Treaty — to impose ‘compulsory licensing’ on companies [Politico, February 3rd]. In fact, last December, the request made by some countries, including India and South Africa, for companies to waive patent exclusivity was rejected by the United States, the UK and the EU [The New York Times, December 25th].

The protection of intellectual property is regulated by the TRIPS (Trade Related Aspects of Intellectual Property Rights) agreement of the World Trade Organization (WTO). The amendment, adopted at the Doha Conference in 2001 and subsequently clarified, provides for the right of a state, in the event of a national health emergency, to produce (or have a third-party produce) a drug without the permission of the company holding the patent on the product or its manufacturing process. In 2017, two-thirds of the WTO membership had ratified the amendment, making it operational.

The compulsory licence could facilitate the entry of new companies into the market, but it still leaves the problem of production capacity for high-technology medicines (such as new vaccines) unsolved.

A kind of ‘vaccine internationalism’ is called for by many. Its realization presupposes, however, the overcoming of barriers and conflicts, commercial and otherwise, between states, and of competition between economic groups; it involves the pooling of resources and productive capacity, the coordination and direction of the global production of vaccines and their distribution according to public needs worldwide. At the very least, it means stripping vaccines of their characteristics of a commodity, which is the form in which the products of human labour are presented in the capitalist social system.

The critics of neoliberalism and globalization stop at the threshold of criticizing the very foundations of the capitalist socio-economic formation. They instead lash out at the excessive power of the banks or the greed of the multinationals, etc., and cultivate the illusion that it is possible to eliminate some of these most odious, but inevitable, forms of capitalism in its imperialistic maturity. Lenin called this wishful thinking.

Production sites for Covid-19 vaccines in the EU and the UK.

Production sites for Covid-19 vaccines in the EU and the UK. In some plants (highlighted in red) the biological active substance is produced, in others the final stages of production, such as bottling and packaging, are carried out. Some of the facilities belong to the company that owns the vaccine, while more than half belong to companies that work on behalf of third parties (CDMO, Contract Development and Manufacturing Organization). Four vaccines are licensed in the EU (BioNTech/Pfizer, Oxford/AstraZeneca, Moderna and J&J); the others are under review by regulatory bodies (CureVac and Novavax) or are still undergoing clinical trials.

Sources: EDJNet — European Data Journalism Network, March 5th, European Commission; corporate communications.

Industrial powers in confrontation

Airfinity calculates that at the end of March the production of Covid-19 vaccines stood at 229 million doses in China, 164 in the US, 125 in India, 110 in the EU (three quarters of which are in Germany, Belgium and the Netherlands), and 16 in the UK. China exported 48%, India 44% and the EU 42%. The USA and the UK have kept all of their doses for their domestic markets [Airfinity, March 24th].

Internal Market Commissioner Thierry Breton believes the EU is winning the industrial battle: producing — he writes — over 200 million doses of vaccines, reaching current levels of production in the US, and the Union’s annual production capacity is expected to reach 3 billion doses by the end of the year. Breton also lays claim to the Union’s role as a top exporter worldwide. At least two-thirds of the 30 million doses administered in Britain were produced in Europe, and the UK depends on the EU for the second dose [European Commission, Beating COVID-19: Scale-up of vaccine production in Europe, April 8th].

Breton refers to 53 production sites for Covid-19 vaccines in Europe. 26% of the facilities are located in Germany. Together with the Netherlands and Belgium, the three countries host 40% of the sites, which in some cases produce more than one type of vaccine. In fact, at least thirty or so plants are owned by companies working on behalf of third parties (CDMO, Contract Development and Manufacturing Organization), of around ten nationalities, mostly German, Spanish and American.

The EU, writes Breton, is an industrial power that is and intends to remain a global player, rejecting vaccine nationalism. The European Commission has, however, since last January, made exports of vaccines subject to authorization. The EU, comments The Economist, is torn between its reputation as champion of open markets and the needs of internal supply [March 27th].

There is an ongoing struggle between the metropolises over health. The production capacity of vaccines, as well as the organisational efficiency in carrying out vaccination strategies — a precondition for a less or more rapid economic recovery — is a measure of the overall strength of states in the global competition.

Lotta Comunista, April 2021

Popular posts in the last week

The EU Commission Plans for Rearmament and a Clean Industrial Deal

Internationalism No. 71, January 2025 Page 2 From the series European news Following the European elections which took place on June 6th - 9th, the leaders of the Member States met on June 27th at the European Council. Ursula von der Leyen was nominated as president of the next European Commission, after she was chosen as the European People’s Party’s (EPP) Spitzenkandidat (“leading candidate”). The agreement also included the election of former Portuguese Prime Minister Antonio Costa as president of the European Council, and the appointment of former Estonian Prime Minister Kaja Kallas as High Representative of the Union for Foreign Affairs and Security Policy. Subsequently, on July 18th, Parliament elected von der Leyen as president of the Commission by an absolute majority, with 401 votes out of 719 MEPs. On September 17th, von der Leyen presented her team of commissioners to the European Parliament and, two days later, the Council adopted this list of...

Lotta Comunista: The Origins 1943-1952

Guido La Barbera Contents 9. Preface to the English Edition 13. Preface 19. Useful dates 21. Chapter One «ONE OUGHT TO KNOW WITH WHOM ONE IS DEALING» 25. The balance-of-power theory 27. Theory and the ‘strategy-party’ 29. Chapter Two THE FOUNDRY AND THE PARTISAN STRUGGLE 31. The Savona group 39. Passion disciplined by reason 40. Never again a tool in the hands of others 41. The Genoa group 46. The Sestri Ponente group 48. The groups in Rome and Tuscany 52. The strength of GAAP: ‘only a handful’ 55. Chapter Three LIBERTARIAN COMMUNISM: A DIFFERENT KIND OF COMMUNISM 58. Reckoning with Bordiga...

India’s Weaknesses in the Global Spotlight

Farmers’ protests around New Delhi have been going on for four months now. A controversial intervention by the Supreme Court has suspended the implementation of the new agticultural laws, but has raised questions about the dynamics between the judiciary and the executive, and has failed to unblock the negotiations between government and peasant organisations. The assault by Sikh farmers on the Red Fort during the Republic Day parade as India was displaying its military might to the outside world — the Chinese Global Times maliciously noted — paradoxically widened the protest in the huge state of Uttar Pradesh. The Modi government has been trying to revive India’s image with the 2021 Union Budget: it announced one hundred privatisations and approved the increase to 75% of the limit on direct foreign investment in insurance companies. For The Indian Express ( IEX ) this is a sign of the commitment to push ahead with reforms despite the backlash from rural India. Also for The Economi...

Innovation Incubators

Internationalism No. 86, April 2026 Page 7 From the series Industry and pharmaceuticals I Since the beginning of the 21 st century, the life sciences sector has undergone profound transformations. Great scientific and technological innovations rooted in the achievements of the 20 th century have affected the whole of the world's healthcare system, revolutionising diagnostic procedures and therapies. However, the fruits of this acceleration of scientific development only reach a minority of humanity. In many cases, the high costs and the limited number of adequate structures — think of gene and cell therapies — make them inaccessible to most of the population, which barely receives even the most basic and lifesaving medicines. Their economic sustainability is a challenge even for the more advanced healthcare and welfare systems. Biotechnology is ...

Cyberspace and the Digital: Between Productive Forces and Ideologies

Internationalism No. 86, April 2026 Page 1 In his 1953 essay, Amadeo Bordiga argues for a very broad conception of economic structure and the means of production : The concept of the ‘economic base’ of a given human society thus extends far beyond the limits of a superficial interpretation confining it to the facts of the remuneration of labour and commercial exchange. It encompasses the entire field of the forms of reproduction of the species, i.e., family institutions; moreover, while the resources of technology and the provision of material instruments and tools of every kind form an integral part of it, its scope is not limited to that of a product showroom, but includes every mechanism available for the transmission from generation to generation of social ‘technological knowledge’. Accordingly, writing, song, music, the graphic arts, and the press, as general networks of communication an...

Show Warfare?

Internationalism No. 86, April 2026 Page 16 After show politics and show diplomacy , have we sunk to the obscenity of show warfare ? On the surface, this is true. The Pentagon’s video game-style communications, where airstrikes, missile launches, and deadly explosions are set to music for social media clips, certainly suggest so. It matters little that a hundred schoolgirls were also blown to bits as artificial intelligence took centre stage on the battlefield. In reality, war propaganda has always showcased destruction and mocked the enemy; today in Washington, in the era of the high-tech groups of television and social media democracy , the only thing that has changed is the style and the means used to inflame fanaticisms and stuff people’s brains. In Tehran, dominated by a parasitic bourgeoisie that feeds on oil revenues and is intertwined with the militias and hierarchies of t...

Historical Constants and Strategic Surprise

The Strategic Surprise of the Agreement between Beijing and Tehran and the Suggestion of a Six-Power Concert The agreement between Beijing and Tehran falls under the definition of strategic surprise , i.e., events that entirely appertain to the political realm and mark a change or an about-turn in the balance among the powers. New alliances, the breakdown of alliances, the overturning of coalitions, diplomatic openings or unexpected military sorties: these are the regular novelties of international politics that Arrigo Cervetto wrote about. However, if the agreement was an unforeseeable event in itself, the long-term objective economic and political trends. that have determined it and made it possible are entirely investigable. The invasion of Afghanistan by the USSR at the end of December 1979 was interpreted by the United States as a potential threat to the oil routes of the Persian Gulf, and it was a contemporary revival of the Great Game , which had set the British Empire agai...

American Improvisation and the Third Gulf War

Internationalism No. 86, April 2026 Pages 4 and 5 According to The Economist , the war that began on February 28th with the American and Israeli attack on Iran has rightly earned the label third Gulf War . A clarification is needed: the war between Iran and Iraq, from 1980 to 1988, cost at least half a million lives and left its mark on the Persian Gulf no less than the subsequent conflicts. However, if we consider only the wars initiated by the United States in an attempt to manage its own decline, the current conflict follows on from those of 1991 and 2003. Hence, the third Gulf War . The conflict has already transcended regional boundaries, involving all countries in the area; the unprecedented assassination of Ali Khamenei, Iran’s religious and political leader, on the first day of the war, was the turning point. The war’s objectives are unclear: it is a war without a strategy , writes The...

Forward Deterrence for European Imperialism

Internationalism No. 86, April 2026 Page 3 From the series European news The next half-century will be the age of nuclear weapons . This was the grim prediction with which Emmanuel Macron concluded his speech on nuclear deterrence, delivered on March 2 nd at the Île Longue submarine base. Standing before Le Téméraire , the nuclear-powered ballistic missile submarine that carries a strike force equivalent to the sum of all the bombs dropped on Europe during the Second World War , the president announced a significant evolution in French nuclear doctrine. The emergence of new threats and the realignment of American priorities make it necessary, according to Macron, not only to strengthen deterrence by increasing the number of nuclear warheads, but also to rethink the deterrence strategy deep inside the European continent . His proposal is the gradual implementation o...

Contested Capital

Internationalism No. 82, December 2025 Page 11 From the series Industry and pharmaceuticals On August 15 th , the White House published a long list of the most recent investments in American manufacturing. The statement emphasised the role of President Donald Trump who, with the aim of revitalising American industry [...], has spurred trillions of dollars of investments in US manufacturing, production, and innovation [ The White House, “Trump Effect: A Running List of New US Investment in President Trump’s Second Term” ]. The list includes around twenty pharmaceutical companies, which have announced a total commitment of over $340 billion in investments, more than half from European companies. Stephen Farrelly, an analyst at ING, estimates that investments in the United States announced by pharmaceutical multinationals amount to more than $400 billion [ Il Sole 24 Ore, October 15 th ]. Political pressures and old problems This i...